PUBLIC COMPANY
saveSpringWorks Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 22Marketed1Unknown
Marketed
mirdametinib ODT
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Marketednirogacestat hydrobromide
Desmoid Tumors
Phase 2mirdametinib
Non-Small Cell Lung Cancer
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Phase 1SW-682
Malignant Mesothelioma
drugOGSIVEO
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Novo workforce down 13,000Follow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 6d ago
- Beeline flies into phase 3 as oral lupus drug soars past placeboA phase 2 trial of Beeline Medicines’ afimetoran has hit its primary endpoint, positioning the biotech to swarm into pivotal development in two forms of lupus.fiercebiotech · 20d ago
- Beeline ups its Series A round for immune drug workThe company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.biopharma_dive · 3mo ago
- Fierce Biotech Layoff Tracker 2026: Enanta sheds staffers; BMS slashes 265 HQ rolesAs always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.fiercebiotech · 9mo ago
- Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 9mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that